Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treating to target in multiple sclerosis: Do we know how to measure whether we hit it?
Bsteh G, Krajnc N, Altmann P, Hendin B, Bharadia T, Jaruszowic S, Lublin F, Oh J, Parow D, Ribbens A, Shields A, Smeets D, Thouvenot E, Chan A, Berger T. Bsteh G, et al. Among authors: lublin f. Eur J Neurol. 2024 Dec;31(12):e16526. doi: 10.1111/ene.16526. Epub 2024 Oct 24. Eur J Neurol. 2024. PMID: 39445673 Free PMC article. Review.
MS becomes a treatable disease: 30 years later.
Lublin FD, Krieger SC. Lublin FD, et al. Mult Scler. 2023 Jun;29(7):789-792. doi: 10.1177/13524585231174781. Epub 2023 May 26. Mult Scler. 2023. PMID: 37232509
Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
Nicholas J, Lublin F, Klineova S, Berwaerts J, Chinnapongse R, Checketts D, Javaid S, Steinerman JR. Nicholas J, et al. Among authors: lublin f. Mult Scler Relat Disord. 2023 Jul;75:104745. doi: 10.1016/j.msard.2023.104745. Epub 2023 May 1. Mult Scler Relat Disord. 2023. PMID: 37209500 Free article. Clinical Trial.
Polygenicity of Comorbid Depression in Multiple Sclerosis.
Kowalec K, Fitzgerald KC, Salter A, Dolovich C, Harder A, Bernstein CN, Bolton J, Cutter GR, Graff LA, Hägg S, Hitchon CA, Lu Y, Lublin F, McKay KA, Patten SB, Patki A, Tiwari HK, Wolinsky JS, Marrie RA. Kowalec K, et al. Among authors: lublin f. Neurology. 2023 Aug 1;101(5):e522-e532. doi: 10.1212/WNL.0000000000207457. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290970 Free PMC article.
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.
Cutter G, Rudick RA, de Moor C, Singh CM, Fisher E, Koster T, Lublin FD, Wolinsky JS, McFarland H, Jacobson S, Naylor ML. Cutter G, et al. Mult Scler J Exp Transl Clin. 2023 Apr 27;9(2):20552173231169463. doi: 10.1177/20552173231169463. eCollection 2023 Apr-Jun. Mult Scler J Exp Transl Clin. 2023. PMID: 37139460 Free PMC article.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
Katz Sand I, Gnjatic S, Krammer F, Tuballes K, Carreño JM, Satyanarayan S, Filomena S, Staker E, Tcheou J, Miller A, Fabian M, Safi N, Nichols J, Patel J, Krieger S, Tankou S, Horng S, Klineova S, Beck E, Merad M, Lublin F. Katz Sand I, et al. Among authors: lublin f. Mult Scler Relat Disord. 2023 Feb;70:104486. doi: 10.1016/j.msard.2022.104486. Epub 2022 Dec 28. Mult Scler Relat Disord. 2023. PMID: 36628884 Free PMC article.
302 results